Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach. (49/86)

Glycopyrrolate and theophylline for the treatment of severe pallid breath-holding spells. (50/86)

In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models. (51/86)

Muscle metaboreflex and autonomic regulation of heart rate in humans. (52/86)

Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. (53/86)

Glycopyrrolate induced bilateral angle closure glaucoma after cervical spine surgery. (54/86)

Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. (55/86)

Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis. (56/86)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10